Data for proteomic analysis of murine cardiomyocytic HL-1 cells treated with siRNA against tissue factor
Maura Brioschi, Sabrina Lento, Simona Barcella, Md. Talat Nasim, Stefania Ghilardi, Silvia Stella Barbieri, Elena Tremoli, Cristina Banfi

TL;DR
This paper provides proteomic data from heart cells treated with siRNA to study the effects of silencing the tissue factor gene.
Contribution
The study reveals a new role for tissue factor in regulating splicing machinery in cardiomyocytic cells.
Findings
Proteomic analysis identified proteins affected by tissue factor gene silencing.
Gene Ontology analysis highlighted changes in splicing machinery-related proteins.
Abstract
This data article is related to the research article entitled Proteomics of Tissue Factor silencing in cardiomyocytic cells reveals a new role for this coagulation factor in splicing machinery control by Lento et al. [1]. Tissue Factor (TF) is a key player in the coagulation cascade, but it has additional functions ranging from angiogenesis, tumour invasion and, in the heart, the maintenance of the integrity of cardiac cells. This article reports the nano-LC–MSE analysis of the cardiomyocytic HL-1 cell line proteome and describes the results obtained from a Gene Ontology analysis of those proteins affected by TF-gene silencing.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMaterial Properties and Applications · Mechanical and Thermal Properties Analysis · Engineering Technology and Methodologies
Specifications tableSubject areaBiologyMore specific subject areaCellular proteomicsType of dataExcel filesHow data was acquiredExperiments were performed on the hybrid quadrupole-time of flight mass spectrometer SYNAPT-G1 (Waters corporation, Milford, MA, USA) coupled to the nanoAQUITY UPLC system (Waters corporation, Milford, MA, USA)Data formatProcessed dataExperimental factorsCardiomyocytic HL-1 cells were treated with TF siRNA or a non-silencing oligonucleotide sequenceExperimental featuresCell lysates were digested with trypsin and analysed by nano-LC–MS^E^ and processed with PLGS 2.3 (Waters corporation, Milford, MA, USA)Data source locationMilan, ItalyData accessibilityData are provided with this article and are related to[1]
Value of the data
- •370 proteins were identified in the cardiomyocytic HL-1 cell line proteome.
- •The data are valuable for the understanding of the protein composition if cardiomyocytes and could be reused by other scientists investigating these cells under various conditions.
- •Computational analysis of differentially expressed proteins following TF gene silencing revealed a novel role of this coagulation factor in the regulation of splicing machinery.
Data, experimental design, materials and methods
1
Cardiomyocitic HL-1 cells were treated with siRNA against TF which resulted a 83.7±5.6% reduction of TF mRNA levels in comparison with cells treated with a non-silencing oligonucleotide sequence. Cell lysates were digested with trypsin and their proteome were compared by a label free nano-LC–MS^E^ analysis which allowed both a qualitative and quantitative analysis of 370 proteins (Supplementary Table 1). Differentially expressed proteins were further investigated with computational analysis for the identification of over-represented GO categories (Supplementary Table 2).
Cell cultures, RNA interference and cell transfection
1.1
The HL-1 cardiomyocytes, gift of Prof. Claycomb (LSU Health Sciences Center, New Orleans, LA, USA), were cultured according to Prof. Claycomb׳s instructions [2]. Gene silencing was performed using small interfering RNAs (siRNA) against TF or a nonsilencing oligonucleotide sequence provided by Qiagen Inc. following the manufacturer׳s instructions as described in [1].
Label-free LC–MSE analysis
1.2
The cell lysates, dissolved in 25 mmol/L NH4HCO3 containing 0.1% RapiGest (Waters Corporation, Milford, MA, USA) were digested as previously described [3]. The tryptic peptides were analysed by means of a nanoACQUITY system coupled to a SYNAPT-MS, a hybrid Q-TOF mass spectrometer (Waters Corporation, Milford, MA, USA), for the LC–MS^E^ analysis as previously described [4].
ProteinLynx GlobalSERVER (PLGS) v 2.3 (Waters Corporation, Milford, MA, USA)was used foriIon detection, data clustering, and database search of the data-independent LC–MS^E^ data as previously explained in detail [[1,5,6]](#bib1 bib5 bib6). The entire data set of differentially expressed proteins was further filtered by considering only the identifications from data with identified peptides that replicated at least two out of three technical instrument replicates and in two out of three biological replicates [1].
Computational analysis
1.3
The list of proteins down-regulated by TF-silencing were further analysed with the BiNGO plugin (v 2.3) in the Cytoscape (v 2.7) software platform in order to make gene ontology (GO) assignments and identify over-represented GO categories for cell component and biological, as previously described [3]. Statistical analysis was obtained using the hypergeometric analysis followed by Benjamini and Hochberg׳s false discovery rate correction (p<0.001) [7].
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Lento S.Brioschi M.Barcella S.Nasim T.Ghilardi S.Barbieri S.S.Tremoli E.Banfi C.Proteomics of Tissue Factor silencing in cardiomyocytic cells reveals a new role for this coagulation factor in splicing machinery control J. Proteomics 119201575892566832610.1016/j.jprot.2015.01.021 · doi ↗ · pubmed ↗
- 2White S.M.Constantin P.E.Claycomb W.C.Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function Am. J. Physiol. Heart Circ. Physiol.2862004 H 823H 8291476667110.1152/ajpheart.00986.2003 · doi ↗ · pubmed ↗
- 3Brioschi M.Lento S.Tremoli E.Banfi C.Proteomic analysis of endothelial cell secretome: a means of studying the pleiotropic effects of Hmg-Co A reductase inhibitors J. Proteomics 7820133463612308522610.1016/j.jprot.2012.10.003 · doi ↗ · pubmed ↗
- 4Brioschi M.Eligini S.Crisci M.Fiorelli S.Tremoli E.Colli SA mass spectrometry-based workflow for the proteomic analysis of in vitro cultured cell subsets isolated by means of laser capture microdissection Anal. Bioanal. Chem.4062014281728252463356510.1007/s 00216-014-7724-9 · doi ↗ · pubmed ↗
- 5Geromanos S.J.Vissers J.P.Silva J.C.Dorschel C.A.Li G.Z.Gorenstein M.V.The detection, correlation, and comparison of peptide precursor and product ions from data independent LC–MS with data dependant LC–MS/MS Proteomics 92009168316951929462810.1002/pmic.200800562 · doi ↗ · pubmed ↗
- 6Li G.Z.Vissers J.P.Silva J.C.Golick D.Gorenstein M.V.Geromanos S.J.Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures Proteomics 92009169617191929462910.1002/pmic.200800564 · doi ↗ · pubmed ↗
- 7Maere S.Heymans K.Kuiper M.Bi NGO: a cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks Bioinformatics 212005344834491597228410.1093/bioinformatics/bti 551 · doi ↗ · pubmed ↗
